FDA COULD CLOSE LOOPHOLE ALLOWING HIMS TO SELL GLP-1 KNOCKOFFS AT ANY TIME AND EXPECTS SHORTAGES TO EASE AS EARLY AS NEXT WEEK Compounding pharmacies face another existential threat: Once shortages ease, the FDA will close the loophole that allows compounding
Not every nutrient in your multivitamin needs to reach 100% of the daily value (DV)
Liver catalase, serum antioxidant capacity, malondialdehyde, and gene expression of interleukin 1 beta and interleukin 6 in the liver were assessed
The FDA has also raised concerns about dosing errors, contamination, impurities and inconsistent ingredients in compounded GLP-1 drugs
CVD: cardiovascular diseases
These drugs are FDA-approved for treating Type 2 diabetes and obesity, with additional benefits for patients with heart disease or sleep apnea